Registration Dossier

Diss Factsheets

Administrative data

Description of key information

Oral rat: LD50 12086 mg/kg

Behavioral: Somnolence (general depressed activity), Convulsions or effect on seizure threshold; Lungs, thorax or respiration: dyspnea (18-20 Vadkovskii per. Moscow, 101479, Russia; History Unknown (2), 25, 1994)

Oral mouse: LD50 3724 mg/kg

Behavioral: somnolence (general depressed activity), convulsions or effect on seizure threshold; Lungs, thorax or respiration: Dyspnea (18-20 Vadkovskii per. Moscow, 101479, Russia; History Unknown (2), 25, 1994)

Inhalation rat: TCLo 41.4 mg/m³/4H

Kidney, Ureter and bladder: other changes in urine composition; blood: changes in serum composition (e.g. TP, bilirubin, cholesterol; Biochemical: Enzyme inhibition, induction or change in blood tissue levels, Phosphatases)

(18-20 Vadkovskii per. Moscow, 101479, Russia; History Unknown (2), 25, 1994)

Read-across data captured from published Benzophenone registration dossier:

Oral mouse (OECD Guideline 401): LD50 ca. 2895 mg/kg bw (Caprino L et al., 1975, Eur J Toxicol Environ Hyg 9, 99-103)

Dermal rabbit (no guideline followed): LD50 3535 mg/kg bw (Opdyke DLJ, 1979, Food Cosmet Toxicol 11, 873-874)

Key value for chemical safety assessment

Additional information

Justification for classification or non-classification

Classification, Labelling, and Packaging Regulation (EC) No 1272/2008

The available experimental test and read-across data is reliable and suitable for classification purposes under Regulation (EC) No 1272/2008, as amended for the seventh time in Regulation (EC) No 2015/1221. As a result the substance is considered to be not classified for acute toxicity.